文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

一种病毒样颗粒,可诱导针对流感病毒血凝素保守茎部的交叉反应性抗体。

A virus-like particle that elicits cross-reactive antibodies to the conserved stem of influenza virus hemagglutinin.

机构信息

Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, USA.

出版信息

J Virol. 2012 Nov;86(21):11686-97. doi: 10.1128/JVI.01694-12. Epub 2012 Aug 15.


DOI:10.1128/JVI.01694-12
PMID:22896619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3486276/
Abstract

The discovery of broadly neutralizing antibodies that recognize highly conserved epitopes in the membrane-proximal region of influenza virus hemagglutinin (HA) has revitalized efforts to develop a universal influenza virus vaccine. This effort will likely require novel immunogens that contain these epitopes but lack the variable and immunodominant epitopes located in the globular head of HA. As a first step toward developing such an immunogen, we investigated whether the 20-residue A-helix of the HA2 chain that forms the major component of the epitope of broadly neutralizing antibodies CR6261, F10, and others is sufficient by itself to elicit antibodies with similarly broad antiviral activity. Here, we report the multivalent display of the A-helix on icosahedral virus-like particles (VLPs) derived from the capsid of Flock House virus. Mice immunized with VLPs displaying 180 copies/particle of the A-helix produced antibodies that recognized trimeric HA and the elicited antibodies had binding characteristics similar to those of CR6261 and F10: they recognized multiple HA subtypes from group 1 but not from group 2. However, the anti-A-helix antibodies did not neutralize influenza virus. These results indicate that further engineering of the transplanted peptide is required and that display of additional regions of the epitope may be necessary to achieve protection.

摘要

广谱中和抗体的发现,这些抗体能够识别流感病毒血凝素(HA)膜近侧区域高度保守的表位,这重新激发了开发通用流感病毒疫苗的努力。这项工作可能需要新型免疫原,这些免疫原包含这些表位,但缺乏位于 HA 球状头部的可变和免疫显性表位。作为开发这种免疫原的第一步,我们研究了 20 个残基的 HA2 链 A 螺旋本身是否足以引发具有类似广谱抗病毒活性的抗体,该 A 螺旋是广谱中和抗体 CR6261、F10 和其他抗体的主要表位组成部分。在这里,我们报告了来自禽痘病毒衣壳的二十面体病毒样颗粒(VLPs)上 A 螺旋的多价展示。用展示 180 个拷贝/颗粒 A 螺旋的 VLPs 免疫的小鼠产生了能够识别三聚体 HA 的抗体,并且诱导的抗体具有与 CR6261 和 F10 相似的结合特性:它们识别来自 1 组的多个 HA 亚型,但不识别来自 2 组的 HA 亚型。然而,抗 A 螺旋抗体不能中和流感病毒。这些结果表明需要进一步对移植肽进行工程改造,并且可能需要展示表位的其他区域才能实现保护。

相似文献

[1]
A virus-like particle that elicits cross-reactive antibodies to the conserved stem of influenza virus hemagglutinin.

J Virol. 2012-8-15

[2]
Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.

J Virol. 2016-9-12

[3]
Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.

J Virol. 2015-3

[4]
Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages.

mBio. 2019-2-26

[5]
H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans.

J Virol. 2011-8-24

[6]
Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges.

J Virol. 2020-12-22

[7]
Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.

J Virol. 2018-5-29

[8]
Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.

J Virol. 2019-3-5

[9]
Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection.

Arch Virol. 2015-3

[10]
Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.

J Virol. 2020-2-28

引用本文的文献

[1]
Administration of antigenically distinct influenza viral particle combinations as an influenza vaccine strategy.

PLoS Pathog. 2025-1-22

[2]
Headless hemagglutinin-containing influenza viral particles direct immune responses toward more conserved epitopes.

J Virol. 2024-10-22

[3]
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine.

NPJ Vaccines. 2024-9-17

[4]
Vaccination with antigenically complex hemagglutinin mixtures confers broad protection from influenza disease.

Sci Transl Med. 2024-5

[5]
Inactivated recombinant influenza vaccine: the promising direction for the next generation of influenza vaccine.

Expert Rev Vaccines. 2024

[6]
Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopes.

PLoS Pathog. 2023-8

[7]
Flagellin-Fused Protein Targeting M2e and HA2 Induces Innate and T-Cell Responses in Mice of Different Genetic Lines.

Vaccines (Basel). 2022-12-8

[8]
Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines.

Front Immunol. 2022

[9]
Protein engineering strategies for rational immunogen design.

NPJ Vaccines. 2021-12-17

[10]
Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for 'Universal' Influenza Vaccines.

Vaccines (Basel). 2021-2-5

本文引用的文献

[1]
A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Science. 2011-7-28

[2]
A highly conserved neutralizing epitope on group 2 influenza A viruses.

Science. 2011-7-7

[3]
Design and characterization of epitope-scaffold immunogens that present the motavizumab epitope from respiratory syncytial virus.

J Mol Biol. 2011-4-27

[4]
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.

J Exp Med. 2011-1-10

[5]
Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus.

Biochem Biophys Res Commun. 2010-11-13

[6]
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes.

Proc Natl Acad Sci U S A. 2010-10-18

[7]
Elicitation of structure-specific antibodies by epitope scaffolds.

Proc Natl Acad Sci U S A. 2010-9-27

[8]
Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope.

Structure. 2010-9-8

[9]
Influenza virus vaccine based on the conserved hemagglutinin stalk domain.

mBio. 2010-5-18

[10]
Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.

Science. 2010-7-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索